| David A Vanengelenhoven, MD | |
|
1300 Anne St Nw, Bemidji, MN 56601-5103 | |
| (218) 333-5000 | |
| (218) 333-5438 |
| Full Name | David A Vanengelenhoven |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 1300 Anne St Nw, Bemidji, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093775900 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 47131 (Minnesota) | Secondary |
| 207Q00000X | Family Medicine | 47131 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Bemidji Medical Center | Bemidji, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Health Of Northern Minnesota | 5597725168 | 258 |
News Archive
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
The current issue of the British Medical Journal online includes a scientific study conducted by the U.S. Centers for Disease Control and Prevention (CDC) that shows that household water treatment with PUR Purifier of Water developed by Procter & Gamble significantly lowers diarrhea in children.
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Recent legislation is encouraging clinical trials in children, including the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
› Verified 8 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532468 PECOS PAC ID: 4284546151 Enrollment ID: O20031209000264 |
News Archive
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
The current issue of the British Medical Journal online includes a scientific study conducted by the U.S. Centers for Disease Control and Prevention (CDC) that shows that household water treatment with PUR Purifier of Water developed by Procter & Gamble significantly lowers diarrhea in children.
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Recent legislation is encouraging clinical trials in children, including the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
› Verified 8 days ago
| Entity Name | Sanford Health Of Northern Minnesota |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770849697 PECOS PAC ID: 5597725168 Enrollment ID: O20041025000442 |
News Archive
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
The current issue of the British Medical Journal online includes a scientific study conducted by the U.S. Centers for Disease Control and Prevention (CDC) that shows that household water treatment with PUR Purifier of Water developed by Procter & Gamble significantly lowers diarrhea in children.
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Recent legislation is encouraging clinical trials in children, including the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Vanengelenhoven, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | David A Vanengelenhoven, MD 1300 Anne St Nw, Bemidji, MN 56601-5103 Ph: (218) 333-5000 |
News Archive
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
The current issue of the British Medical Journal online includes a scientific study conducted by the U.S. Centers for Disease Control and Prevention (CDC) that shows that household water treatment with PUR Purifier of Water developed by Procter & Gamble significantly lowers diarrhea in children.
Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.
Recent legislation is encouraging clinical trials in children, including the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.
› Verified 8 days ago
Brian Paul Livermore, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 619 5th St Nw, Bemidji, MN 56601 Phone: 218-751-4144 Fax: 218-751-3545 | |
Steven J Quamme, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5180 Fax: 218-333-5360 | |
James Braunwarth, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000 | |
Jill Olson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1611 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000 | |
William G Dicks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1611 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5111 | |
David W Wilcox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000 | |
Maria K Statton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5180 Fax: 218-759-5438 |